INTRAUTERINE INSEMINATION FOR CERVICAL AND MALE FACTOR WITHOUT SUPEROVULATION

被引:9
作者
CHECK, JH [1 ]
BOLLENDORF, A [1 ]
ZACCARDO, M [1 ]
LURIE, D [1 ]
VETTER, B [1 ]
机构
[1] UNIV MED & DENT NEW JERSEY,COOPER HOSP,ROBERT WOOD JOHNSON MED SCH,DEPT OBSTET & GYNECOL,CAMDEN,NJ
来源
ARCHIVES OF ANDROLOGY | 1995年 / 35卷 / 02期
关键词
INTRAUTERINE INSEMINATION; SUPEROVULATION; HOSTILE MUCUS; SUBNORMAL SEMEN PARAMETERS; LIFE-TABLE ANALYSIS;
D O I
10.3109/01485019508987864
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Intrauterine insemination (IUI) has been used for the treatment of various causes of infertility, including unexplained infertility, male factor, and cervical factor. Some centers frequently use superovulation combined with IUI. The study presented herein attempted to evaluate the efficacy of IUI without superovulation in cases where all causes of infertility other than cervical or male factors have been eliminated. However, in the case of poor or absent cervical mucus, the use of controlled ovarian hyperstimulation (COH) may obscure the actual importance of the IUI, since it is possible that the poor cervical mucus is related to poor timing, inadequate follicular maturation, or low estradiol levels, which if corrected will obviate the need for IUI. In this study IUI was targeted for 36-40 h following the sera luteinizing hormone surge. A total of 108 patients were enrolled in this study: 47 with male factor, 61 with cervical factor. Patients were followed for a maximum of three cycles unless a pregnancy occurred within 3 months of treatment. Comparison of pregnancy rates (PRs) were based on diagnosis. The cumulative PRs per cycle for each of the three cycles studied were as follows: cervical factor-19.7, 36.8, and 36.8%; male factor-12.8, 29.3, and 38.3%. Thus, PRs were comparable for both groups after three treatment cycles. These data demonstrate that IUI is an effective therapy for cervical and/or male factor, even without superovulation.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 28 条
[1]  
ABOULGHAR MA, 1993, FERTIL STERIL, V60, P303
[2]  
ALLEN NC, 1985, FERTIL STERIL, V44, P569
[3]  
ARICI A, 1994, FERTIL STERIL, V61, P314
[4]   THE USE OF CHYMOTRYPSIN/GALACTOSE TO TREAT SPERMATOZOA BOUND WITH ANTISPERM ANTIBODIES PRIOR TO INTRAUTERINE INSEMINATION [J].
BOLLENDORF, A ;
CHECK, JH ;
KATSOFF, D ;
FEDELE, A .
HUMAN REPRODUCTION, 1994, 9 (03) :484-488
[5]  
BRONSON R, 1984, FERTIL STERIL, V42, P171
[6]  
CHECK JH, 1986, INT J FERTIL, V31, P148
[7]  
CHECK JH, 1989, FERTIL STERIL, V52, P159
[8]  
CHECK JH, 1992, INT J FERTIL, V37, P33
[9]   THE EFFICACY OF SHORT-TERM GONADOTROPIN-RELEASING-HORMONE AGONISTS VERSUS HUMAN CHORIONIC-GONADOTROPIN TO ENABLE OOCYTE RELEASE IN GONADOTROPIN STIMULATED CYCLES [J].
CHECK, JH ;
NAZARI, A ;
BARNEA, ER ;
WEISS, W ;
VETTER, BH .
HUMAN REPRODUCTION, 1993, 8 (04) :568-571
[10]   EVALUATION OF SPERM MORPHOLOGY USING KRUGER STRICT CRITERIA [J].
CHECK, JH ;
ADELSON, HG ;
SCHUBERT, BR ;
BOLLENDORF, A .
ARCHIVES OF ANDROLOGY, 1992, 28 (01) :15-17